RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,000 | -33.3% | 584 | -46.5% | 0.00% | – |
| Q2 2023 | $3,000 | 0.0% | 1,092 | -32.7% | 0.00% | – |
| Q1 2023 | $3,000 | -91.7% | 1,622 | -84.2% | 0.00% | – |
| Q4 2022 | $36,000 | -85.4% | 10,291 | +54.6% | 0.00% | – |
| Q3 2022 | $246,000 | +100.0% | 6,658 | +2.7% | 0.00% | – |
| Q2 2022 | $123,000 | -42.0% | 6,484 | -17.5% | 0.00% | – |
| Q1 2022 | $212,000 | -1.4% | 7,856 | -17.6% | 0.00% | – |
| Q4 2021 | $215,000 | -16.3% | 9,537 | -2.8% | 0.00% | – |
| Q3 2021 | $257,000 | -15.7% | 9,811 | +3.0% | 0.00% | – |
| Q2 2021 | $305,000 | -6.4% | 9,527 | +2.7% | 0.00% | – |
| Q1 2021 | $326,000 | -58.4% | 9,277 | -62.0% | 0.00% | – |
| Q4 2020 | $783,000 | -14.8% | 24,399 | -0.1% | 0.00% | – |
| Q3 2020 | $919,000 | +91800.0% | 24,426 | +93846.2% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 26 | -27.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |